Novo Nordisk Seeks FDA Approval of Higher Dose of Wegovy Weight-Loss Shot

The Food and Drug Administration is set to treat application under its priority program that seeks to accelerate the review ...
Everyday Health on MSN

Zepbound vs. Wegovy: Which Obesity Treatment Might Be Right for You?

Wegovy and Zepbound are 2 FDA-approved injectables for weight loss. Learn how they compare in benefits, side effects, and ...
Seeking Alpha

Wegovy® approved by FDA for the treatment of adults with noncirrhotic MASH with moderate to advanced liver fibrosis

PLAINSBORO, N.J., Aug. 15, 2025 /PRNewswire/ -- Novo Nordisk (NVO) today announced that the US Food and Drug Administration (FDA) has approved a new indication for Wegovy ® (semaglutide) injection 2.4 ...
WebMD

FDA Approves Wegovy as First Once-Weekly Injection for Obesity-Linked Liver Disease

Wegovy (semaglutide) is a once-weekly injection that was first approved in 2017 to help with weight loss and lower the risk of heart problems. Now, the FDA has approved it to treat a liver condition ...
KVOA 4

Company behind Wegovy testing obesity pill

COPENHAGEN (KVOA) - Novo Nordisk said Wednesday that late-stage trial results for its once-daily obesity pill showed “significant” weight reduction and tolerability in line with its blockbuster Wegovy ...
Reuters

Wall Street sees new obesity pills as priced near Wegovy and Zepbound

Novo and Lilly first-to-market with weight-loss injections Pills seen priced in line with current injectable drugs Lilly pill easier to make at scale than Novo's Novo pill more effective than Lilly's ...
Becker's Hospital Review

Novo Nordisk seeks FDA approval of higher-dose Wegovy

Through the FDA’s priority voucher program, Novo Nordisk said Nov. 26 it has filed an application seeking approval of its Wegovy 7.2 milligram injection.  Wegovy (semaglutide) is currently approved in ...